Claude C Bernard
Claude C Bernard
Emeritus Professor, Australian Regenerative Medicine Institute, Monash University, Melbourne
Email verificata su
Citata da
Citata da
The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease
D Chabas, SE Baranzini, D Mitchell, CCA Bernard, SR Rittling, ...
Science 294 (5547), 1731-1735, 2001
IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis.
DO Willenborg, S Fordham, CC Bernard, WB Cowden, IA Ramshaw
Journal of immunology (Baltimore, Md.: 1950) 157 (8), 3223-3227, 1996
TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination
J Liu, MW Marino, G Wong, D Grail, A Dunn, J Bettadapura, AJ Slavin, ...
Nature medicine 4 (1), 78-83, 1998
High-flow nasal oxygen vs noninvasive positive airway pressure in hypoxemic patients after cardiothoracic surgery: a randomized clinical trial
F Stéphan, B Barrucand, P Petit, S Rézaiguia-Delclaux, A Médard, ...
Jama 313 (23), 2331-2339, 2015
Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis
V Brundula, NB Rewcastle, LM Metz, CC Bernard, VW Yong
Brain 125 (6), 1297-1308, 2002
Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis
JL McQualter, R Darwiche, C Ewing, M Onuki, TW Kay, JA Hamilton, ...
The Journal of experimental medicine 194 (7), 873-882, 2001
Limited heterogeneity of rearranged T-cell receptor Vα transcripts in brains of multiple sclerosis patients
JR Oksenberg, S Stuart, AB Begovich, RB Bell, HA Erlich, L Steinman, ...
Nature 345 (6273), 344-346, 1990
Selection for T-cell receptor Vβ–Dβ–Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis
JR Oksenberg, MA Panzara, AB Begovich, D Mitchell, HA Erlich, ...
Nature 362 (6415), 68-70, 1993
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study
C Charlier, É Perrodeau, A Leclercq, B Cazenave, B Pilmis, B Henry, ...
The Lancet Infectious Diseases 17 (5), 510-519, 2017
Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial
A Hartemann, G Bensimon, CA Payan, S Jacqueminet, O Bourron, ...
The lancet Diabetes & endocrinology 1 (4), 295-305, 2013
MHC class II–dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies
N Molnarfi, U Schulze-Topphoff, MS Weber, JC Patarroyo, T Prod’homme, ...
Journal of Experimental Medicine 210 (13), 2921-2937, 2013
Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein.
NK De Rosbo, R Milo, MB Lees, D Burger, CC Bernard, A Ben-Nun
The Journal of clinical investigation 92 (6), 2602-2608, 1993
B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions
SE Baranzini, MC Jeong, C Butunoi, RS Murray, CCA Bernard, ...
The Journal of Immunology 163 (9), 5133-5144, 1999
Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis
CCA Bernard, TG Johns, A Slavin, M Ichikawa, C Ewing, J Liu, ...
Journal of molecular medicine 75, 77-88, 1997
The structure and function of myelin oligodendrocyte glycoprotein
TG Johns, CCA Bernard
Journal of neurochemistry 72 (1), 1-9, 1999
Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial
M Rosenzwajg, R Lorenzon, P Cacoub, HP Pham, F Pitoiset, K El Soufi, ...
Annals of the rheumatic diseases 78 (2), 209-217, 2019
Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy
L Steinman, R Martin, C Bernard, P Conlon, JR Oksenberg
Annual review of neuroscience 25 (1), 491-505, 2002
B‐cell activation influences T‐cell polarization and outcome of anti‐CD20 B‐cell depletion in central nervous system autoimmunity
MS Weber, T Prod'Homme, JC Patarroyo, N Molnarfi, T Karnezis, ...
Annals of neurology 68 (3), 369-383, 2010
The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination
T Karnezis, W Mandemakers, JL McQualter, B Zheng, PP Ho, KA Jordan, ...
Nature neuroscience 7 (7), 736-744, 2004
Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis
WH Robinson, P Fontoura, BJ Lee, HEN De Vegvar, J Tom, R Pedotti, ...
Nature biotechnology 21 (9), 1033-1039, 2003
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20